Aardvark Therapeutics, Inc. · NASDAQ:AARD
Citadel Advisors LLC reported a 5.60% stake in Aardvark Therapeutics, Inc. (Schedule 13G)
Event Feb 14, 2025 · Filed Feb 24, 2025
Citadel Advisors LLC reported a 5.60% stake in Aardvark Therapeutics, Inc., 1,192,971 shares, as a passive investor on Feb 14, 2025. Filed Feb 24, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 1,192,971
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 5.40% | 1,152,375 |
| Citadel Advisors Holdings LP | 5.40% | 1,152,375 |
| Citadel GP LLC | 5.40% | 1,152,375 |
| Citadel Securities LLC | 0.20% | 40,596 |
| Citadel Securities Group LP | 0.20% | 40,596 |
| Citadel Securities GP LLC | 0.20% | 40,596 |
| Kenneth Griffin | 5.60% | 1,192,971 |